# Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients

> **NCT07510308** · PHASE1 · RECRUITING · sponsor: **West China Hospital** · enrollment: 9 (estimated)

## Conditions studied

- pMMR/MSS Advanced Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Low Dose MSH2-/- tumor cell vaccine
- **BIOLOGICAL:** Medium Dose MSH2-/- tumor cell vaccine
- **BIOLOGICAL:** High dose MSH2-/- tumor cell vaccine

## Key facts

- **NCT ID:** NCT07510308
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07510308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07510308, "Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07510308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*